Management of Essential Hypertension |
Contents
Dedication Preface and Acknowledgments | 1 |
Management of Malignant or Accelerated Hypertension | 12 |
THIAZIDES | 21 |
Copyright | |
49 other sections not shown
Other editions - View all
Common terms and phrases
action activity acute addition administration adverse reactions agents antihypertensive antihypertensive agent appears arterial associated blocking blood pressure body cardiac cause changes chapter chlorothiazide Clin clinical clonidine combination comparison daily decreased depression develop diabetic diazoxide discontinued disease diuretic dosage doses drug edema essential hypertension et al excretion failure Figure frequent function furosemide given glucose guanethidine half-life heart hydralazine hydrochlorothiazide hypertensive patients hypokalemia hypotension incidence increased indicated induced initial Intern intravenous JAMA Lancet less levels liver lower mean mechanism Medical methyldopa mg/day mild moderate myocardial infarction nitroprusside normal occur oral patients receiving Pharmacol physician plasma positive potassium potential prazosin prevent produce propranolol rare rauwolfia reduced reference renal renin reported require reserpine response result salt serum potassium severe side effects significant sodium spironolactone studies symptoms syndrome TABLE Ther therapy thiazide tion toxicity treated treatment of hypertension triamterene usually vasodilator